Arrowhead Research Corporation (ARWR)
Last updated: 2026-10-21 03:48:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Arrowhead Research Corporation (ARWR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $58.90, with a market capitalization of $7.90B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $36.73 to $95.49. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.90B | |
$57.07 | |
$95.49 | |
$1.20 | |
$57.23 | |
1.39M | |
1.88M | |
-- | |
$95.49 | |
$36.73 | |
-- | |
2001-09-29 |
Arrowhead Research Corporation (ARWR) Latest Closing Stock Price
Arrowhead Research Corporation (ARWR) last closed at $57.23 as of 2026-10-20 23:58:00, unchanged from the previous close of $57.23.
During the latest regular trading session, ARWR traded between $1.20 and $95.49, with a volume of 1.39M shares. The closing price was near the middle and near the middle of its 52-week range.
Arrowhead Research Corporation (ARWR) 7-Day Stock Price Change
Over the past seven days, Arrowhead Research Corporation (ARWR) moved from $62.75 to $58.90, representing a decline of 6.13% ($3.85).
The stock traded between $55.83 and $62.99 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 2.26 million shares, up versus the previous seven-day period, indicating higher trading activity.
ARWR 52-Week Price Position
Position in Range: 37.7%
ARWR is currently trading at $58.90, placing it 37.7% of the way from its 52-week low of $36.73 to its 52-week high of $95.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Arrowhead Research Corporation (ARWR)?
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Arrowhead Research Corporation Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 711 |
| CEO | Christopher R. Anzalone |
| Founded | 2003 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Arrowhead Research Corporation (ARWR) Stock on MEXC
Eligible investors can buy real shares of Arrowhead Research Corporation (ARWR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Arrowhead Research Corporation (ARWR) stock price today?
2.Is ARWR stock going up or down today?
3.What is ARWR pre-market price?
4.What is ARWR after-hours price?
5.Is ARWR stock trading now?
6.Where does ARWR sit relative to its 52-week high and low?
7.What sector is Arrowhead Research Corporation in?
8.What is Arrowhead Research Corporation's market capitalization and where is it listed?
9.How is ARWR valued in terms of P/E ratio and EPS?
10.Does Arrowhead Research Corporation pay a dividend?
Explore More US Stocks
Search Stocks
ARWR Stock Calculator
Estimate the value between ARWR shares and USD.
ARWR Shares to USD
1.00 ARWR shares = 58.903 USD
Calculations are estimates based on the latest available price and are for reference only.


